Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2022
Japanese linguistic validation of the ureteral stent symptom questionnaireJunichi Matsuzaki, Sataoshi Takahashi, Akito Yamaguchi, et al.
Molecular and Clinical Oncology|May 8, 2018
A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 casesMasakazu Akitake, Keijiro Kiyoshima, Akira Yokomizo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 18, 2015
Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a phase III randomized clinical trialOsamu Yokoyama, Akito Yamaguchi, Masaki Yoshida, et al.
Cancer Genetics and Cytogenetics|March 14, 2007
Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancerHideyasu Matsuyama, Kazuo Oba, Kenji Matsuda, et al.
BJU International|March 19, 2016
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flareMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
Japanese Journal of Clinical Oncology|February 11, 2017
Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomyNobuaki Sato, Masaki Shiota, Ken-Ichiro Shiga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 20, 2015
Non-inferiority of silodosin 4 mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: a multicenter, randomized, parallel-group studyNarihito Seki, Ryosuke Takahashi, Akito Yamaguchi, et al.
Japanese Journal of Clinical Oncology|September 3, 2004
Efficacy of modest dose irradiation in combination with long-term endocrinal treatment for high-risk prostate cancer: a preliminary reportTomonari Sasaki, Katsumasa Nakamura, Yoshiyuki Shioyama, et al.
Investigational New Drugs|August 25, 2019
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinomaShunji Takahashi, Motohide Uemura, Tomokazu Kimura, et al.
BMC Urology|November 6, 2016
Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experimentHiroji Uemura, Nobuaki Matsubara, Go Kimura, et al.
Pageof 5